LENZ Therapeutics (LENZ) Interest & Investment Income (2022 - 2026)
LENZ Therapeutics' (LENZ) quarterly Interest & Investment Income came in at $2.6 million in Q1 2026, up 13.82% year-on-year from $2.3 million in Q1 2025, and up 17526.67% on a QoQ basis from $15000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Interest & Investment Income (2022 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 5 years of Interest & Investment Income data on file, last reported at $2.6 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 13.82% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 2.23% increase from a year earlier, with the FY2025 full-year figure at $46000.0, down 75.79% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.6 million, up from $15000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for LENZ reached as high as $2.7 million in Q3 2024 and fell as low as -$724000.0 in Q2 2022.
- Historically, Interest & Investment Income has averaged $661250.0 across 5 years, with a median of $1000.0 in 2023.
- Across the five-year window, Interest & Investment Income sank 335.71% in 2024 and soared 33285.71% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $548000.0 in 2022, then jumped by 300.36% to $2.2 million in 2023, then sank by 114.9% to -$327000.0 in 2024, then jumped by 104.59% to $15000.0 in 2025, then surged by 17526.67% to $2.6 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $2.6 million in Q1 2026, $15000.0 in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | LENZ Therapeutics | 177.61 Mn | -80.77 Mn | 825,000.00 | 2.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.64 Mn |
| Dec 31, 2025 | 15,000.00 |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | -85,000.00 |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | -327,000.00 |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | -61,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | 2.19 Mn |
| Sep 30, 2023 | 9,000.00 |
| Jun 30, 2023 | -14,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | -563,000.00 |
| Jun 30, 2022 | -724,000.00 |
| Mar 31, 2022 | -309,000.00 |